TotalMarketCap

NeuroPace

NPCENasdaq United StatesHealth CareMedical/Dental Instruments

Market cap

$434.545 M

$12.66 -5.10%

Close of 6 Nov 2026

As of 6 Nov 2026, NeuroPace (NPCE) has a market capitalization of $434.5M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$100.0M

#2483 by revenue

Earnings

-$21.5M

Loss-making

Shares outstanding

34,324,274

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Medical/Dental Instruments, ranked by market cap

All 124 →
  1. #48AVITA MedicalRCEL$489.8M
  2. #49Mimedx GroupMDXG$476.4M
  3. #50NeuroPaceNPCE$434.5M
  4. #51CerusCERS$429.8M
  5. #52Shoulder InnovationsSI$426.8M

What if NeuroPace were worth as much as…

Open the what-if tool →

Gold $28.2T

$822,650.29

Per share 64,980× higher

Bitcoin $1.53T

$44,512.17

Per share 3,516× higher

Apple $5.02T

$146,129.31

Per share 11,543× higher

Or at a round number

$1.00B$2.00B$5.00B$10.0B

Where these numbers come from

Share counts and financials for NeuroPace are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.